Literature DB >> 26998763

T cell-intrinsic ASC critically promotes T(H)17-mediated experimental autoimmune encephalomyelitis.

Bradley N Martin1,2, Chenhui Wang1,3, Cun-jin Zhang1,4,5, Zizhen Kang6, Muhammet Fatih Gulen1, Jarod A Zepp1, Junjie Zhao1, Guanglin Bian1, Jeong-su Do1, Booki Min1, Paul G Pavicic1, Caroline El-Sanadi7, Paul L Fox8, Aoi Akitsu9, Yoichiro Iwakura9, Anasuya Sarkar10, Mark D Wewers10, William J Kaiser11, Edward S Mocarski11, Marc E Rothenberg12, Amy G Hise13, George R Dubyak7, Richard M Ransohoff14, Xiaoxia Li1.   

Abstract

Interleukin 1β (IL-1β) is critical for the in vivo survival, expansion and effector function of IL-17-producing helper T (T(H)17) cells during autoimmune responses, including experimental autoimmune encephalomyelitis (EAE). However, the spatiotemporal role and cellular source of IL-1β during EAE pathogenesis are poorly defined. In the present study, we uncovered a T cell-intrinsic inflammasome that drives IL-1β production during T(H)17-mediated EAE pathogenesis. Activation of T cell antigen receptors induced expression of pro-IL-1β, whereas ATP stimulation triggered T cell production of IL-1β via ASC-NLRP3-dependent caspase-8 activation. IL-1R was detected on T(H)17 cells but not on type 1 helper T (T(H)1) cells, and ATP-treated T(H)17 cells showed enhanced survival compared with ATP-treated T(H)1 cells, suggesting autocrine action of T(H)17-derived IL-1β. Together these data reveal a critical role for IL-1β produced by a T(H)17 cell-intrinsic ASC-NLRP3-caspase-8 inflammasome during inflammation of the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26998763      PMCID: PMC5385929          DOI: 10.1038/ni.3389

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  47 in total

1.  Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.

Authors:  Ingunn M Stromnes; Lauren M Cerretti; Denny Liggitt; Robert A Harris; Joan M Goverman
Journal:  Nat Med       Date:  2008-02-17       Impact factor: 53.440

2.  Norepinephrine triggers release of glial ATP to increase postsynaptic efficacy.

Authors:  Grant R J Gordon; Dinara V Baimoukhametova; Sarah A Hewitt; W R A Kosala J S Rajapaksha; Thomas E Fisher; Jaideep S Bains
Journal:  Nat Neurosci       Date:  2005-07-03       Impact factor: 24.884

3.  Interferon-β therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasome.

Authors:  Makoto Inoue; Kristi L Williams; Timothy Oliver; Peter Vandenabeele; Jayant V Rajan; Edward A Miao; Mari L Shinohara
Journal:  Sci Signal       Date:  2012-05-22       Impact factor: 8.192

4.  Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection.

Authors:  Gilad Doitsh; Nicole L K Galloway; Xin Geng; Zhiyuan Yang; Kathryn M Monroe; Orlando Zepeda; Peter W Hunt; Hiroyu Hatano; Stefanie Sowinski; Isa Muñoz-Arias; Warner C Greene
Journal:  Nature       Date:  2014-01-23       Impact factor: 49.962

5.  Pannexin-1 is required for ATP release during apoptosis but not for inflammasome activation.

Authors:  Yan Qu; Shahram Misaghi; Kim Newton; Laurie L Gilmour; Salina Louie; James E Cupp; George R Dubyak; David Hackos; Vishva M Dixit
Journal:  J Immunol       Date:  2011-04-20       Impact factor: 5.422

6.  Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis.

Authors:  Zizhen Kang; Cengiz Zubeyir Altuntas; Muhammet Fatih Gulen; Caini Liu; Natalia Giltiay; Hongwei Qin; Liping Liu; Wen Qian; Richard M Ransohoff; Cornelia Bergmann; Stephen Stohlman; Vincent K Tuohy; Xiaoxia Li
Journal:  Immunity       Date:  2010-03-18       Impact factor: 31.745

7.  Activation of inflammasomes requires intracellular redistribution of the apoptotic speck-like protein containing a caspase recruitment domain.

Authors:  Nicole B Bryan; Andrea Dorfleutner; Yon Rojanasakul; Christian Stehlik
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

8.  Signaling through the adaptor molecule MyD88 in CD4+ T cells is required to overcome suppression by regulatory T cells.

Authors:  Dominik Schenten; Simone A Nish; Shuang Yu; Xiting Yan; Heung Kyu Lee; Igor Brodsky; Lesley Pasman; Brian Yordy; F Thomas Wunderlich; Jens C Brüning; Hongyu Zhao; Ruslan Medzhitov
Journal:  Immunity       Date:  2014-01-16       Impact factor: 31.745

9.  The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation.

Authors:  Muhammet F Gulen; Zizhen Kang; Katarzyna Bulek; Wan Youzhong; Tae Whan Kim; Yi Chen; Cengiz Z Altuntas; Kristian Sass Bak-Jensen; Mandy J McGeachy; Jeong-Su Do; Hui Xiao; Greg M Delgoffe; Booki Min; Jonathan D Powell; Vincent K Tuohy; Daniel J Cua; Xiaoxia Li
Journal:  Immunity       Date:  2010-01-07       Impact factor: 31.745

10.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

Authors:  Marc Veldhoen; Richard J Hocking; Christopher J Atkins; Richard M Locksley; Brigitta Stockinger
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

View more
  63 in total

1.  RNA-Binding Protein HuR Promotes Th17 Cell Differentiation and Can Be Targeted to Reduce Autoimmune Neuroinflammation.

Authors:  Jing Chen; Jennifer L Martindale; Kotb Abdelmohsen; Gaurav Kumar; Paolo M Fortina; Myriam Gorospe; Abdolmohamad Rostami; Shiguang Yu
Journal:  J Immunol       Date:  2020-03-13       Impact factor: 5.422

Review 2.  Inflammasomes and adaptive immune responses.

Authors:  Katherine A Deets; Russell E Vance
Journal:  Nat Immunol       Date:  2021-02-18       Impact factor: 25.606

3.  TLR-stimulated IRAKM activates caspase-8 inflammasome in microglia and promotes neuroinflammation.

Authors:  Cun-Jin Zhang; Meiling Jiang; Hao Zhou; Weiwei Liu; Chenhui Wang; Zizhen Kang; Bing Han; Quanri Zhang; Xing Chen; Jianxin Xiao; Amanda Fisher; William J Kaiser; Masanori A Murayama; Yoichiro Iwakura; Ji Gao; Julie Carman; Ashok Dongre; George Dubyak; Derek W Abbott; Fu-Dong Shi; Richard M Ransohoff; Xiaoxia Li
Journal:  J Clin Invest       Date:  2018-10-29       Impact factor: 14.808

4.  IL-1β enables CNS access to CCR2hi monocytes and the generation of pathogenic cells through GM-CSF released by CNS endothelial cells.

Authors:  Alexandre Paré; Benoit Mailhot; Sébastien A Lévesque; Camille Juzwik; Prenitha Mercy Ignatius Arokia Doss; Marc-André Lécuyer; Alexandre Prat; Manu Rangachari; Alyson Fournier; Steve Lacroix
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-22       Impact factor: 11.205

Review 5.  The IL-1β phenomena in neuroinflammatory diseases.

Authors:  Andrew S Mendiola; Astrid E Cardona
Journal:  J Neural Transm (Vienna)       Date:  2017-05-22       Impact factor: 3.575

6.  Structures of the Gasdermin D C-Terminal Domains Reveal Mechanisms of Autoinhibition.

Authors:  Zhonghua Liu; Chuanping Wang; Joseph K Rathkey; Jie Yang; George R Dubyak; Derek W Abbott; Tsan Sam Xiao
Journal:  Structure       Date:  2018-03-22       Impact factor: 5.006

7.  Crucial role of P2X7 receptor for effector T cell activation in experimental autoimmune uveitis.

Authors:  Atsunobu Takeda; Hisakata Yamada; Eiichi Hasegawa; Mitsuru Arima; Shoji Notomi; Sayaka Myojin; Takeru Yoshimura; Toshio Hisatomi; Hiroshi Enaida; Ryoji Yanai; Kazuhiro Kimura; Tatsuro Ishibashi; Koh-Hei Sonoda
Journal:  Jpn J Ophthalmol       Date:  2018-03-23       Impact factor: 2.447

Review 8.  New Insights into the Role of IL-1β in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.

Authors:  Chih-Chung Lin; Brian T Edelson
Journal:  J Immunol       Date:  2017-06-15       Impact factor: 5.422

Review 9.  Comprehensive review of ASC structure and function in immune homeostasis and disease.

Authors:  Ishan Agrawal; Sushmita Jha
Journal:  Mol Biol Rep       Date:  2020-03-02       Impact factor: 2.316

Review 10.  Inflammasomes: Threat-Assessment Organelles of the Innate Immune System.

Authors:  Charles L Evavold; Jonathan C Kagan
Journal:  Immunity       Date:  2019-08-28       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.